Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
about
Effect of diabetes mellitus on mycophenolate sodium pharmacokinetics and inosine monophosphate dehydrogenase activity in stable kidney transplant recipientsSafety considerations with mycophenolate sodium.Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review.Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.
P2860
Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Efficacy and safety of enteric ...... es from three clinical trials.
@en
Efficacy and safety of enteric ...... es from three clinical trials.
@nl
type
label
Efficacy and safety of enteric ...... es from three clinical trials.
@en
Efficacy and safety of enteric ...... es from three clinical trials.
@nl
prefLabel
Efficacy and safety of enteric ...... es from three clinical trials.
@en
Efficacy and safety of enteric ...... es from three clinical trials.
@nl
P2093
P2860
P1476
Efficacy and safety of enteric ...... es from three clinical trials.
@en
P2093
Bernard Bourbigot
Frank Pietruck
Frederic Oppenheimer
Hans Sollinger
Klemens Budde
Maurizio Salvadori
Miguel Angel Gentil
P2860
P304
P356
10.1111/J.1399-0012.2006.00615.X
P577
2007-01-01T00:00:00Z